Almost none of it currently comes through a licensed pharmacy, for the simple reason that compounding BPC-157 isnt legally allowed yet
Patient selection and protocol design matter more than dose alone
In the US and most of Europe, domestic price drops are more likely after key patent protections expire in the early 2030s
(3) Inhibiting Adipose Tissue Inflammation and Improving the Adipose Microenvironment In obesity, adipose tissue develops chronic lowgrade inflammation with abundant release of proinflammatory factors (such as TNF and IL6), disrupting the adipose microenvironment, further worsening fat metabolic abnormalities and insulin resistance, and forming a vicious cycle
A few therapies are approved to treat ALS, but their ability to slow disease progression and extend survival is limited
Trends in Endocrinology & Metabolism